Evaluation of ColdZyme Mouth Spray for the Protection against Common Cold in Elite Athletes to Reduce Unwanted Absence from Training and Competition

ISSN Print: 2163-940X
ISSN Online: 2163-9418
www.scirp.net/journal/ojrd
E-mail: [email protected]

Citations

"Evaluation of ColdZyme Mouth Spray for the Protection against Common Cold in Elite Athletes to Reduce Unwanted Absence from Training and Competition"
written by Mats Clarsund,
published by Open Journal of Respiratory Diseases, Vol.7 No.3, 2017

has been cited by the following article(s):

[1]	Does Trypsin Oral Spray (Viruprotect®/ColdZyme®) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the …
	2021

[2]	Does Trypsin Oral Spray (Viruprotect®/ColdZyme®) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device …
	International Journal of …, 2021

[3]	ColdZyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions.
	2020

[4]	Coldzyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions
	2020

[5]	COLDZYME MUNSPRAY
	2019

[6]	User Experience of ColdZyme Mouth Spray against Common Cold in Competitive Athletes
	2018

[7]	Rinofaryngit, akut (förkylning)
	2018

[1]	Does Trypsin Oral Spray (Viruprotect®/ColdZyme®) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union International Journal of Environmental Research and Public Health, 2021 DOI:10.3390/ijerph18105066

[2]	Coldzyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions European Journal of Sport Science, 2020 DOI:10.1080/17461391.2020.1771429

[3]	User Experience of ColdZyme Mouth Spray against Common Cold in Competitive Athletes Open Journal of Respiratory Diseases, 2018 DOI:10.4236/ojrd.2018.82002